Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care.

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMID 25824498)

Published in CMAJ on March 30, 2015

Authors

Canadian Task Force on Preventive Health Care, Patricia Parkin, Sarah Connor Gorber, Elizabeth Shaw, Neil Bell, Alejandra Jaramillo, Marcello Tonelli, Paula Brauer

Articles cited by this

Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med (1997) 19.30

2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10

Interventions for preventing obesity in children. Cochrane Database Syst Rev (2011) 8.81

The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics (2005) 4.95

Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med (2011) 4.61

Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. Pediatrics (2010) 4.53

Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA (2010) 4.33

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58

Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care (2008) 2.73

Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA (2005) 2.58

Effectiveness of home based early intervention on children's BMI at age 2: randomised controlled trial. BMJ (2012) 2.47

Overweight and obesity in children and adolescents: results from the 2009 to 2011 Canadian Health Measures Survey. Health Rep (2012) 2.39

Parental underestimates of child weight: a meta-analysis. Pediatrics (2014) 2.35

Overweight and obesity among children and youth. Health Rep (2006) 2.23

Tracking of obesity and physical activity from childhood to adulthood: the Physical Activity Longitudinal Study. Int J Pediatr Obes (2009) 2.03

Canadian childhood obesity estimates based on WHO, IOTF and CDC cut-points. Int J Pediatr Obes (2010) 1.62

How early should obesity prevention start? N Engl J Med (2013) 1.51

Process for guideline development by the reconstituted Canadian Task Force on Preventive Health Care. CMAJ (2012) 1.39

A parent-focused intervention to reduce infant obesity risk behaviors: a randomized trial. Pediatrics (2013) 1.26

Obesity in childhood and vascular changes in adulthood: insights into the Cardiovascular Risk in Young Finns Study. Int J Obes (Lond) (2005) 1.16

Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocr Pract (2006) 1.10

Evaluation of an intervention to promote protective infant feeding practices to prevent childhood obesity: outcomes of the NOURISH RCT at 14 months of age and 6 months post the first of two intervention modules. Int J Obes (Lond) (2012) 1.08

Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger. JAMA Pediatr (2014) 1.06

Defining the complexity of childhood obesity and related behaviours within the family environment using structural equation modelling. Public Health Nutr (2011) 1.03

Prevention of overweight and obesity in children and youth: a systematic review and meta-analysis. CMAJ Open (2015) 0.99

Periodic health examination, 1994 update: 1. Obesity in childhood. Canadian Task Force on the Periodic Health Examination. CMAJ (1994) 0.96

Treatment of overweight and obesity in children and youth: a systematic review and meta-analysis. CMAJ Open (2015) 0.94

Obesity, Complexity, and the Role of the Health System. Curr Obes Rep (2013) 0.89

Articles by these authors

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act (2008) 7.32

Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int (2011) 6.21

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? CMAJ (2001) 6.08

Systematic review of sedentary behaviour and health indicators in school-aged children and youth. Int J Behav Nutr Phys Act (2011) 5.91

Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31

The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension (2011) 5.14

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10

Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2001) 4.69

Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ (2011) 4.68

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56

Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51

Recommendations on screening for prostate cancer with the prostate-specific antigen test. CMAJ (2014) 3.46

Recommendations on screening for cervical cancer. CMAJ (2013) 3.32

Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26

Early recognition and prevention of chronic kidney disease. Lancet (2010) 3.19

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med (2011) 3.13

Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. CMAJ (2015) 3.11

Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation (2005) 3.10

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int (2005) 3.03

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97

Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet (2010) 2.95

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int (2008) 2.88

Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84

Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA (2010) 2.61

Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58

Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int (2008) 2.56

Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54

Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med (2011) 2.48

Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43

New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ (2003) 2.39

Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA (2012) 2.38

Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2007) 2.38

Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int (2004) 2.37

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32

Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29

Fitness of Canadian adults: results from the 2007-2009 Canadian Health Measures Survey. Health Rep (2010) 2.28

Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA (2008) 2.22

Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22

Population based screening for chronic kidney disease: cost effectiveness study. BMJ (2010) 2.19

CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis (2009) 2.17

Proteinuria and life expectancy. Am J Kidney Dis (2012) 2.16

Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med (2003) 2.13

Impact of anemia on hospitalization and mortality in older adults. Blood (2006) 2.07

Renewing postgraduate family medicine education: the rationale for Triple C. Can Fam Physician (2011) 2.07

Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol (2008) 2.06

Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med (2008) 2.06

Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol (2001) 2.02

Quality control and data reduction procedures for accelerometry-derived measures of physical activity. Health Rep (2010) 2.02

Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant (2012) 2.01

Systematic review of physical activity and health in the early years (aged 0-4 years). Appl Physiol Nutr Metab (2012) 1.98

Prevention of violence against women: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2003) 1.93

Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2004) 1.93

Access to health care among status Aboriginal people with chronic kidney disease. CMAJ (2008) 1.91

Chronic kidney disease and life expectancy. Nephrol Dial Transplant (2012) 1.90

Screening for depression in primary care: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2005) 1.89

Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int (2010) 1.89

Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J Am Soc Nephrol (2011) 1.89

Fitness of Canadian children and youth: results from the 2007-2009 Canadian Health Measures Survey. Health Rep (2010) 1.88

Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 1.85

Estimates of obesity based on self-report versus direct measures. Health Rep (2008) 1.85

Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2012) 1.84

Canadian Health Measures Survey: rationale, background and overview. Health Rep (2007) 1.79

Pharmacoeconomic modeling of prior-authorization intervention for COX-2 specific inhibitors in a 3-tier copay plan. J Manag Care Pharm (2003) 1.78

The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med (2009) 1.77

Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011. Perit Dial Int (2011) 1.76

NSAID use and progression of chronic kidney disease. Am J Med (2007) 1.75

Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ (2001) 1.74

Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol (2006) 1.74

Systematic review of sedentary behaviour and health indicators in the early years (aged 0-4 years). Appl Physiol Nutr Metab (2012) 1.73

Economic evaluation of sevelamer in patients with end-stage renal disease. Nephrol Dial Transplant (2007) 1.73

Continuity: middle C--a very good place to start. Can Fam Physician (2011) 1.70

Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol (2011) 1.70

Canadian Physical Activity Guidelines for the Early Years (aged 0-4 years). Appl Physiol Nutr Metab (2012) 1.67

Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol (2013) 1.65

Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol (2007) 1.60

Kidney stones and kidney function loss: a cohort study. BMJ (2012) 1.58

A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease. Clin J Am Soc Nephrol (2012) 1.57

Canadian Sedentary Behaviour Guidelines for the Early Years (aged 0-4 years). Appl Physiol Nutr Metab (2012) 1.57

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev (2014) 1.55